TauTona Group, a medical device incubator and investor focused on the rapid development of innovative surgical products, announced this morning the sale of its Surgical Marker technology to Novadaq Technologies. The Surgical Marker is designed to work with select imaging procedures such as those done with Novadaq's SPY Fluorescence Imaging System, which is used in reconstructive surgical procedures, and LUNA, which is used to assess perfusion in patients with non-healing wounds, TauTona said. Financial terms of the sale were not disclosed.
- Health Care Industry
- Tests & Procedures